US Appeals Court Blocks Grant Program for Black Women-Owned Businesses usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
(Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer. The ruling on Friday by Judge Vivian Medinil.
A Delaware judge has allowed more
than 70,000 lawsuits over discontinued heartburn drug Zantac to
go forward, ruling that expert witnesses can testify in court
that the drug may cause cancer. .
A Delaware judge has permitted more than 70,000 lawsuits regarding the discontinued heartburn medication Zantac to move forward. Expert witnesses will testify that the drug may cause cancer, a claim disputed by the drug's former makers, GSK, Pfizer, Sanofi, and Boehringer Ingelheim. The companies are planning to appeal.
A Delaware judge has allowed over 70,000 lawsuits against Zantac to proceed, citing expert witnesses claiming the drug may cause cancer. The drugmakers GSK, Pfizer, Sanofi, and Boehringer Ingelheim are set to appeal. In 2020, the FDA ordered Zantac's removal from the market due to cancer risk concerns.